OMMH
Price:
$0.0001
Market Cap:
$981.00
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monocl...[Read more]
Industry
Biotechnology
IPO Date
2022-12-30
Stock Exchange
OTC
Ticker
OMMH
According to Omnimmune Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is 38.41%. This represents a change of 367.97% compared to the average of 8.21% of the last 4 quarters.
The mean historical ROE of Omnimmune Holdings, Inc. over the last ten years is 43.48%. The current 38.41% ROE has changed -11.66% with respect to the historical average. Over the past ten years (40 quarters), OMMH's ROE was at its highest in in the September 2008 quarter at 31.03%. The ROE was at its lowest in in the August 2007 quarter at -737.51%.
Average
43.48%
Median
17.09%
Minimum
-20.24%
Maximum
159.97%
Discovering the peaks and valleys of Omnimmune Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 9.16%
Maximum Annual ROE = 159.97%
Minimum Annual Increase = -108.54%
Minimum Annual ROE = -20.24%
| Year | ROE | Change |
|---|---|---|
| 2009 | 32.46% | -79.71% |
| 2008 | 159.97% | 9.16% |
| 2008 | 1.73% | -108.54% |
The current ROE of Omnimmune Holdings, Inc. (OMMH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
64.72%
5-year avg
43.48%
10-year avg
43.48%
Omnimmune Holdings, Inc.’s ROE is greater than IMV Inc. (-489.29%), less than eFFECTOR Therapeutics, Inc. (3.77%), greater than ContraFect Corporation (-347.26%), greater than Adynxx, Inc. (-70.38%), greater than DMK Pharmaceuticals Corporation (-209.88%), less than BioELife Corp. (170.28%), less than Grupo International Inc. (8.69%), less than Adhera Therapeutics, Inc. (8.94%), less than Proteonomix, Inc. (38.77%), greater than Minerva Surgical, Inc. (-111.32%),
| Company | ROE | Market cap |
|---|---|---|
| -489.29% | $117.00 | |
| 3.77% | $941.00 | |
| -347.26% | $1.07K | |
| -70.38% | $581.00 | |
| -209.88% | $1.01K | |
| 170.28% | $1.88K | |
| 8.69% | $1.04K | |
| 8.94% | $722.00 | |
| 38.77% | $791.00 | |
| -111.32% | $8.88K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Omnimmune Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Omnimmune Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Omnimmune Holdings, Inc.'s ROE?
How is the ROE calculated for Omnimmune Holdings, Inc. (OMMH)?
What is the highest ROE for Omnimmune Holdings, Inc. (OMMH)?
What is the 3-year average ROE for Omnimmune Holdings, Inc. (OMMH)?
What is the 5-year average ROE for Omnimmune Holdings, Inc. (OMMH)?
How does the current ROE for Omnimmune Holdings, Inc. (OMMH) compare to its historical average?